Peer-Review Report of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (4584)
All Articles published online
|
Publishing Process of This Article
|
Jul 16, 2024 (publication date) through May 20, 2026
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Clinical Cases
ISSN
2307-8960
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| Li YN, Su JL, Tan SH, Chen XL, Cheng TL, Jiang Z, Luo YZ, Zhang LM. Machine learning based on metabolomics unveils neutrophil extracellular trap-related metabolic signatures in non-small cell lung cancer patients undergoing chemoimmunotherapy. World J Clin Cases 2024; 12(20): 4091-4107 [PMID: 39015934 DOI: 10.12998/wjcc.v12.i20.4091] |
|
|
|
| All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply. | |
| For: | Li YN, Su JL, Tan SH, Chen XL, Cheng TL, Jiang Z, Luo YZ, Zhang LM. Machine learning based on metabolomics unveils neutrophil extracellular trap-related metabolic signatures in non-small cell lung cancer patients undergoing chemoimmunotherapy. World J Clin Cases 2024; 12(20): 4091-4107 [PMID: 39015934 DOI: 10.12998/wjcc.v12.i20.4091] |
|---|---|
| URL: | https://www.wjgnet.com/2307-8960/full/v12/i20/4091.htm |
| Number | Citing Articles |
| 1 |
Xue Yang, Liyuan Yin, Zhuoying Tian, Qinghua Zhou. Intratumoral Microbiota in Lung Cancer: Emerging Roles in TME Modulation and Immunotherapy Response. International Journal of Molecular Sciences 2025; 27(1): 255 doi: 10.3390/ijms27010255
|
| 2 |
Peter May, Christof Winter, Inga Hubrecht, Adrian Patenge, Selina Strathmeyer, Roland Geyer, Steffen Heelemann, Jan Stratmann, Seyer Safi, Henriette Klein, Folker Schneller, Florian Bassermann, Aaron Becker von Rose. Serum metabolomic signatures predict clinical outcomes in advanced non-small cell lung cancer treated with pembrolizumab plus platinum-based chemotherapy. Frontiers in Immunology 2026; 17 doi: 10.3389/fimmu.2026.1770764
|
| 3 |
Zhiwei Xu, Jingjing Li. Comprehensive multi omics profiling and Mendelian randomization assessment of lipid metabolites in lung cancer prognosis. Discover Oncology 2026; 17(1) doi: 10.1007/s12672-026-04893-6
|
| 4 |
Sara Bertorello, Francesco Cei, Dorian Fink, Elena Niccolai, Amedeo Amedei. The Future Exploring of Gut Microbiome-Immunity Interactions: From In Vivo/Vitro Models to In Silico Innovations. Microorganisms 2024; 12(9): 1828 doi: 10.3390/microorganisms12091828
|
| 5 |
Dunpeng Yang, Wentian Zhang, Qibin Wang. A comprehensive analysis through Mendelian randomization of immunological markers and sphingolipid metabolism. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03224-5
|